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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S136their isolation. The absence of cross-reaction with the IIA isoform was
established by ELISA andWB. In addition, the Saos-2 cell linewas chosen to
test a possible labelling of other ﬁbrillar procollagens, mainly type I, V and
XI. In fact, this cell line is described to synthesize the (a1)I, (a2)I, (a1)V,
(a2)V, (a1)XI and (a2)XI, but no (a3)XI chains. No signal was detected on
WB of cellular extracts or conditioned media with anti-pNIIB52, whereas
antibodies to the collagen I, V and XI triple-helical parts revealed indeed
the presence of proforms of these collagens.
Conclusions: Anti-pNIIB52 antibodies allow a very sensitive and speciﬁc
detection of the procollagen IIB, the protein synthesized by mature chon-
drocytes. No cross-reactions with the IIA or with the major ﬁbrillar pro-
collagens synthesized by cells with an osteoblastic phenotype were
observed. These antibodies offer a new tool in basic aswell as in translational
research concerning cartilage differentiation, homeostasis and repair.
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INFLUENCE OF OXYGEN TENSION ON THE ANTI-INFLAMMATORY AND
CHONDROPROTECTIVE EFFECTS OF HEME OXYGENASE-1 IN HEALTHY
AND OSTEOARTHRITIC HUMAN CHONDROCYTES
M. Guillén 1,2, V. Clérigues 3, F. Gomar 4, C.L. Murphy 5, M. Alcaraz 3. 1Univ.
of Valencia, Burjasot, Valencia, Spain; 2CEU Cardenal Herrera Univ.,
Moncada, Spain; 3Univ. of Valencia, Burjasot, Valencia, Spain; 4Univ. of
Valencia, Valencia, SPAIN; 5Kennedy Inst. of Rheumatology, London, United
Kingdom
Purpose: Articular chondrocytes are adapted to live in conditions of low
O2. Such hypoxic conditions in the avascular cartilage play an important
role in extracellular matrix synthesis and survival of chondrocytes. In
previous work we have shown anti-inﬂammatory and chondroprotective
effects of heme oxygenase-1 (HO-1) on osteoarthritic (OA) condrocytes in
primary cultures in 20% O2. However, the inﬂuence of O2 tension on HO-1
function in healthy and OA chondrocytes remains unknown.
Methods: Human chondrocytes were obtained from healthy donors and
patients with diagnosis of advanced OA undergoing total knee joint
replacement. The chondrocyteswere isolated bydigestionwith collagenase
and used in primary culture. Healthy and OA chondrocyes were cultured in
20%or 1%O2 tension, and in 5%CO2. Cellswere stimulatedwith IL-1b (10 ng/
ml) for 48h. HO-1 was induced by incubation with 10 mM cobalt proto-
porphyrin IX (CoPP). Protein expression was assessed by Western blot,
ELISA and immunocytochemistry. Nitrite production and matrix metal-
loproteinase (MMP) activity were evaluated by ﬂuorometric methods. HO-
1 gene silencing was achieved by using a gene-speciﬁc siRNA.
Results: HO-1 proteinwas expressed in both healthy and OA chondrocytes
in hypoxia (1% O2) and normoxia (20% O2). IL-1b down-regulated HO-1
expression in all conditions whereas CoPP treatment counteracted this
effect. CoPP treatment was able to reduce the levels of TNFa and MMP
activity after IL-1b stimulation. CoPP also decreased the production of
nitrite induced by IL-1b in healthy and OA cells at both O2 concentrations.
This effect was accompanied by a reduction in iNOS expression at 24h. In
hypoxic conditions HIF-2a and SOX9 expression was decreased by IL-1b in
both healthy and OA chondrocytes. However, HO-1 induction was able to
reverse this effect and prevented the decrease in type collagen II. In
addition, IL-1b induced HIF-1a expression irrespective of O2 tension
whereas HO-1 induction by CoPP down-regulated HIF-1a expression in OA
chondrocytes only.
Conclusions: HO-1 induction in primary chondrocytes cultured in hypoxic
conditions resulted in stronger anti-inﬂammatory and chondroprotective
effects compared with normoxia. These results suggest that HO-1 could be
a physiologically important chondroprotective factor.
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HUMAN OSTEOARTHRITIS SYNOVIUM CONTAINS AN ALTERNATIVELY
SPLICED TRANSCRIPT OF ADAMTS4
S. Wainwright 1, J. Bondeson 2, C. Hughes 1, B. Caterson 1. 1Cardiff Sch. of
BioSci.s, Cardiff, United Kingdom; 2Dept of Rheumatology, Cardiff Univ.,
Cardiff, United Kingdom
Purpose: The characterization of an alternatively spliced transcript of the
ADAMTS4 aggrecanase.Methods: In human OA synovial cell cultures, RT-PCRwas performed using
oligonucleotide primers designed to amplify across the exon 8/9 region of
human ADAMTS4. The PCR products were puriﬁed using a QIAquick
puriﬁcation kit (Qiagen) and sequenced using in house facilities. A pCEP4
(Invitrogen) mammalian expression vector containing ADAMTS4 plus
a FLAG epitope was mutated using the QuikChange II site directed muta-
genesis kit (Stratagene) to contain the ADAMTS4 splice variant plus a FLAG
epitope. The recombinant proteins were puriﬁed from HEK293 transfected
cells using Anti-FLAG M2 afﬁnity gel (Sigma). Polyclonal antibodies were
raised against synthetic peptides representing sequences within the
C-terminal region of the splice variant of ADAMTS4 and the raised anti-
bodies were characterized using the recombinant splice variant of
ADAMTS4. The antibodies were used in immunohistochemical analysis of
human osteoarthritic synovium. The proteolysis of aggrecan and other
proteoglycans by the recombinant spice variant of ADAMTS4 was
investigated.
Results: The degradation of aggrecan is mainly mediated by the aggreca-
nases, of which ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2)
are the best known. We here characterize an alternative splice variant of
ADAMTS4.
RT-PCR performed as described above resulted in the ampliﬁcation of
normal ADAMTS4, and also a smaller product missing 161 base pairs from
the 5’ end of exon 9, the result of alternative splicing in which exon 8 joins
to a cryptic 3’ splice site within exon 9. The protein produced by this
alternative splicing would lack the spacer domain and have a C-terminus
lacking any homologies with the normal ADAMTS4 spacer domain. The
alternatively spliced transcript of ADAMTS4 was found in cultured OA
synovial cells and in freshly digested OA synovium, but not in human brain,
cervix or lung, or in normal bovine synovium. The protein synthesized
from this alternatively spliced transcript of ADAMTS4 would lose functions
dependent on its spacer domain, like substrate and matrix binding, and
inhibition through ﬁbronectin. Removal of the spacer domain from
ADAMTS4 has been reported to increase its ability to cleave aggrecan at the
Glu373-Ala374 bond, and it may well be that the alternatively spliced
transcript produces a protein that is secreted in a more active form.
HEK293 cells transfected with a pCEP4 vector containing the cDNA
sequence of the splice variant of ADAMTS4 produced the corresponding
protein in both the pro and active form. This protein could be found in the
media, but mostly associated with the cells, as conﬁrmed using antibodies
speciﬁc for the splice variant that were produced using synthetic peptides.
Immunohistochemical analysis of osteoarthritic synovium using these
antibodies showed staining of cells within the synovium. Proteins puriﬁed
by immunoprecipitation by Anti-FLAGM2 afﬁnity gel from transfected and
untransfected HEK293 cells were analysed using the ANASpec SensoLyte
520 Aggrecanase I assay kit. The splice variant had aggrecanase activity
comparable to a commercially available ADAMTS4. The splice variant
cleaved aggrecan at the G1u373-A1a374 site, as assessed by the neoepitope
monoclonal antibody BC3, with activity comparable to ADAMTS4.
Conclusions: ADAMTS4 is regulated at multiple levels through control of
gene expression, mRNA splicing and protein processing, as well as the
expression of naturally occurring inhibitors. We here describe the char-
acteristics of the ﬁrst known splice variant of ADAMTS4. This alternative
splice transcript of ADAMTS4 is expressed as a protein in vivo and can be
found in the synovium. It can be speculated that the changes in the
C-terminal domain of the protein resulting from this alternatively spliced
transcript would have changes in its substrate speciﬁcity. The protein
produced by the alternative spliced transcript of ADAMTS4 has aggreca-
nase activity, and the release of low levels of this fully active variant of
ADAMTS4 might be a factor in the slow process of superﬁcial zone
aggrecan loss in osteoarthritis.
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ANGIOPOIETIN-LIKE 4 PROMOTES TERMINAL CHONDROGENIC
DIFFERENTIATION
M. Mathieu 1,2, P. Chuchana 1,2, M. Iampietro 1,2, D. Noël 1,2,
C. Jorgensen 1,2. 1 Inserm U844, Montpellier, France; 2Université
Montpellier 1, Montpellier, France
Purpose: Mesenchymal stem cells (MSCs) are an attractive cell source for
cartilage tissue engineering given their ability to differentiate into
